ROBERT AUCIAUX - 09 May 2022 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
Director
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
09 May 2022
Net transactions value
-$238,091
Form type
4
Filing time
11 May 2022, 17:11:29 UTC
Previous filing
27 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +10,630 +1625% 11,284 09 May 2022 Direct F1
transaction USNA Common Stock Tax liability $238,091 -3,192 -28% $74.59 8,092 09 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Deferred Stock Units Options Exercise -10,630 -100% 0 09 May 2022 Common Stock 10,630 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

ROBERT AUCIAUX is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted.
F2 The reporting person's service on the issuer's Board of Directors terminated on February 9, 2022. Per the individual's equity grant agreements, the issuer is distributing shares of common stock equal to the number of DSU's previously granted to the reporting person.